Skip to main content

Table 1 Baseline Characteristics in Subjects with MetS and without MetS

From: Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study

 

With MetS

n = 384 (34.4%)

Without MetS

n = 731 (65.6%)

P-value*

Age (years)

63.7 ± 9.2

61.1 ± 9.7

0.0001

Gender

0.05

 Women

206 (53.6%)

347 (47.5%)

 

 Men

178 (46.4%)

384 (52.5%)

 

Residence

0.0001

 Rural

244 (63.5%)

539 (73.7%)

 

 Urban

140 (36.5%)

192 (26.3%)

 

Education

0.219

 High school or lower

193 (50.3%)

341 (46.6%)

 

 Graduated from high school

150 (39.1%)

324 (44.3%)

 

 University degree

41 (10.7%)

66 (9.0%)

 

Marital status

0.152

 Currently married

260 (67.7%)

531 (72.6%)

 

 Never married

20 (5.2%)

40 (5.5%)

 

 Divorced or widower

104 (27.1%)

160 (21.9%)

 

Employment status

0.002

 Currently employed

71 (18.5%)

188 (25.7%)

 

 Currently unemployed

43 (11.2%)

108 (14.8%)

 

 Retired/disabled

270 (70.3%)

435 (59.5%)

 

Current smoking

0.329

 Non-smokers

266 (69.3%)

478 (65.4%)

 

 Smokes 1–9 cigarettes/day

19 (4.9%)

54 (7.4%)

 

 Smokes 10–19 cigarettes/day

38 (9.9%)

69 (9.4%)

 

 Smokes ≥20 cigarettes/day

61 (15.9%)

130 (17.8%)

 

Alcohol consumption

0.024

 Non-consumers

54 (14.1%)

71 (9.7%)

 

 Several times/year

210 (54.7%)

384 (52.5%)

 

 Monthly or more

120 (31.2%)

276 (37.8%)

 

Physical activity a

0.0001

 Several times/month or more

75 (19.5%)

124 (17.0%)

 

 Several times/year

75 (19.5%)

256 (35.0%)

 

 Non-active

234 (60.9%)

351 (48.0%)

 

Past medical histories

 Myocardial infarction

33 (8.6%)

29 (4.0%)

0.001

 Stroke

26 (6.8%)

28 (3.8%)

0.030

 Cardiovascular disorders

275 (71.6%)

388 (53.1%)

0.0001

 Respiratory disorders

138 (35.9%)

232 (31.7%)

0.157

 Gastrointestinal disorders

131 (34.1%)

241 (33.0%)

0.70

 Musculoskeletal disorders

204 (53.1%)

387 (52.9%)

0.953

 Neurological disorders

86 (22.4%)

175 (23.9%)

0.563

 Genitourinary tract disorders

110 (28.6%)

187 (25.6%)

0.271

 Type 2 diabetes mellitus

45 (11.7%)

8 (1.1%)

0.0001

 Other endocrine disorders

103 (26.8%)

118 (16.1%)

0.0001

 Other diseases

135 (35.2%)

231 (31.6%)

0.230

Current medication use

 ACE inhibitors

144 (37.5%)

97 (13.3%)

0.0001

 Beta-blockers

41 (10.7%)

29 (4.0%)

0.0001

 Calcium channel blockers

43 (11.2%)

26 (3.6%)

0.0001

 Other medication

98 (25.5%)

107 (14.6%)

0.0001

Current MINI mental disorders

 Generalized Anxiety Disorder

116 (30.2%)

153 (20.9%)

0.001

 Major Depressive Episode

97 (25.3%)

104 (14.2%)

0.0001

  1. Values are expressed as no. of subjects (%) or mean ± SD
  2. ACE angiotensin-converting-enzyme inhibitor, MINI Mini International Neuropsychiatric Interview, SD standard deviation
  3. aAt least 30 min of physical exercise per day
  4. * p value were calculated using independent sample t-test or Pearson’s chi-squared test
  5. In bold p values <0.05